Home Tags Kinase

Tag: Kinase

Disease course in a patient with TEN (SCORTEN 4) associated with cancer treatment. Disease progression was observed during high-dose intravenous methylprednisolone treatment and the patient developed persistent hyperglycaemia. JAK1i rescue therapy with abrocitinib was initiated on day 4, resulting in visible cessation of progression within 48 h and initial re-epithelialization within 4 days. Top, photographs of the back of the patient, showing the degree of re-epithelialization at the indicated timepoints after hospital admission. Bottom, Treatment schedule. Arrow marks start of abrocitinib treatment. Study: Spatial proteomics identifies JAKi as treatment for a lethal skin disease

Breakthrough Study Reveals JAK Inhibitors as Promising Treatment for Life-Threatening Skin...

Leah Sirama - 0
Neuroactive drugs show promising anti-glioblastoma effects in preclinical trials

Breakthrough in Cancer Research: Neuroactive Drugs Demonstrate Promising Anti-Glioblastoma Effects in...

Leah Sirama - 0

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

©